Hudson Bay Capital Management LP trimmed its position in EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) by 59.8% during the third quarter, Holdings Channel reports. The firm owned 320,000 shares of the company’s stock after selling 476,100 shares during the quarter. Hudson Bay Capital Management LP’s holdings in EUDA Health were worth $555,000 as of its most recent filing with the SEC.
Separately, Citadel Advisors LLC raised its stake in EUDA Health by 57.7% in the third quarter. Citadel Advisors LLC now owns 44,631 shares of the company’s stock valued at $78,000 after buying an additional 16,321 shares during the period. 4.35% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
EUDA has been the subject of several research analyst reports. Greenridge Global reduced their target price on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. Weiss Ratings restated a “sell (d)” rating on shares of EUDA Health in a research note on Friday, January 9th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $55.00.
EUDA Health Stock Performance
Shares of EUDA stock opened at $7.10 on Tuesday. EUDA Health Holdings Limited has a 52 week low of $6.42 and a 52 week high of $86.00. The company has a market capitalization of $268.45 million, a price-to-earnings ratio of -59.17 and a beta of -0.11. The company has a 50-day simple moving average of $20.53 and a 200 day simple moving average of $38.22.
About EUDA Health
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.
See Also
Want to see what other hedge funds are holding EUDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report).
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
